Ledger.Open graph →
SEC Form D · filed August 18, 2015

Ovid Therapeutics Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Matthew J. During · New York, NYExec · DirectorJeremy M. Levin · New York, NYExec · DirectorRodney J. Ball · Concord, NCExec · DirectorBill Hubbard · Concord, NCExec · DirectorYaron M. Werber · New York, NYExecNeil R. Senturia · La Jolla, CAExec · DirectorBradley Messmer · San Diego, CAExec · DirectorYaron M. Werber · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗